The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
The Joint Corp.NASDAQ: JYNT
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $396.69K rose 2.2% year over year, ahead of the -53.5% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 10.4% from the prior quarter. Over 3 fiscal years it compounded at -36.4% a year.
Context
- Depreciation & amortization amounted to 3.1% of revenue in FY2025, down 5.9 pp from a year earlier.
- Depreciation & amortization increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +2.2% holds above the trailing-twelve-month pace of -53.5%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 1.71M USD
- Year-over-year change
- -63.7%
- 4-year CAGR
- -18.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.71M | -63.7% |
| FY2024 | 2024-12-31 | 4.72M | -45.0% |
| FY2023 | 2023-12-31 | 8.58M | +29.1% |
| FY2022 | 2022-12-31 | 6.65M | +69.5% |
| FY2021 | 2021-12-31 | 3.92M | — |
Depreciation & Amortization vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 depreciation & amortization of $1.72M is the 5th highest of the 11 companies compared; the peer median is $895K.
- Its year-over-year change of -53.5% is the 10th highest of 11, against a peer median of +4.4%.
- Depreciation & amortization amounts to 3.0% of revenue for JYNT, versus a peer median of 7.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $17.82M | +30.0% | +4.2% | 14.4% | |
| LTM Mar 2026 | $14.55M | -5.9% | +14.0% | 4.8% | |
| LTM Mar 2026 | $3.79M | +15.6% | +18.6% | 2.0% | |
| LTM Mar 2026 | $3.11M | -4.9% | +4.7% | 9.0% | |
| LTM Mar 2026 | $1.72M | -53.5% | -36.4% | 3.0% | |
| LTM Mar 2026 | $917K | +9.7% | +7.5% | 1608.8% | |
| LTM Mar 2026 | $873K | -1.6% | -23.3% | 17.0% | |
| LTM Mar 2026 | $687K | +18.4% | -9.7% | 1.2% | |
| LTM Mar 2026 | $251K | -0.8% | -1.0% | — | |
| LTM Mar 2026 | $47.85K | +47.9% | +108.0% | — | |
| LTM Mar 2026 | $23.95K | -96.6% | -41.3% | 6.0% | |
| Peer median (excluding JYNT) | $895K | +4.4% | +4.4% | 7.5% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 80.01M | 101.25M | 46.98M | 52.16M | 54.9M |
| Cost of Revenue | 7.67M | 9.17M | 10.48M | 11.52M | 11.23M |
| Gross Profit | 72.35M | 92.08M | 36.5M | 40.65M | 43.67M |
| Gross Margin | 90.4% | 90.9% | 77.7% | 77.9% | 79.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 62.27M | 81.95M | 34.92M | 41.1M | 42.93M |
| Operating Expenses | 66.22M | 91.25M | 36.18M | 42.54M | 44.58M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| EBITDA | 10.07M | 7.89M | 8.88M | 2.9M | 1.48M |
| EBITDA Margin | 12.6% | 7.8% | 18.9% | 5.6% | 2.7% |
| Operating Income | 6.13M | 828.25K | 318.3K | (1.89M) | (905.48K) |
| Operating Margin | 7.7% | 0.8% | 0.7% | -3.6% | -1.6% |
| Interest Income | 0 | 133.1K | 0 | 280.29K | 0 |
| Interest Expense | 0 | 953.53K | 64.29K | 0 | 0 |
| Other Income / Expenses | (69.88K) | (133.1K) | (64.29K) | 280.29K | 675.97K |
| Income Before Tax | 6.06M | 695.15K | 254.01K | (1.61M) | (229.5K) |
| Pre-Tax Margin | 7.6% | 0.7% | 0.5% | -3.1% | -0.4% |
| Income Tax Expense | (1.51M) | 68.45K | 11.02M | 5.61K | 38.65K |
| Net Income | 7.57M | 626.71K | (9.75M) | (5.8M) | 2.91M |
| Net Margin | 9.5% | 0.6% | -20.8% | -11.1% | 5.3% |
| EPS (Basic) | 0.46 | 0.04 | (0.66) | (0.39) | 0.19 |
| EPS (Diluted) | 0.44 | 0.04 | (0.66) | (0.39) | 0.19 |
| Weighted Avg Shares | 14.32M | 14.49M | 14.69M | 14.92M | 15.13M |
| Weighted Avg Shares (Diluted) | 14.94M | 14.87M | 14.69M | 15.15M | 15.13M |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.